pmid	doi	year	title	Hugo_Symbol
33297669	10.3324/haematol.2020.267294	2022	Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.	NOTCH1
34624096	10.1182/blood.2020010405	2022	ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.	NOTCH1
34669156	10.1007/s11684-021-0877-y	2022	Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.	NOTCH1
34814054	10.1016/j.tice.2021.101674	2022	Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway.	NOTCH1
34882582	10.1172/JCI153283	2022	Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.	NOTCH1
34937946	10.1038/s41586-021-04244-1	2022	Valine tRNA levels and availability regulate complex I assembly in leukaemia.	NOTCH1
35014081	10.1002/ddr.21911	2022	Mitoquinone intravitreal injection ameliorates retinal ischemia-reperfusion injury in rats involving SIRT1/Notch1/NADPH axis.	NOTCH1
35014928	10.1080/10428194.2021.2020779	2022	Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.	NOTCH1
35020836	10.1182/blood.2021012077	2022	Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.	NOTCH1
35106936	10.1002/cam4.4550	2022	SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.	NOTCH1
35129045	10.1080/10428194.2022.2032033	2022	Prognostic significance of <i>NOTCH1/FBXW7</i> mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol.	NOTCH1
35173274	10.1038/s41375-022-01516-1	2022	Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL.	NOTCH1
35231988	10.3760/cma.j.issn.0253-2727.2022.01.005	2022	[Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].	NOTCH1
35240234	10.1016/j.canlet.2022.215608	2022	DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.	NOTCH1
35245453	10.1016/j.molcel.2022.02.015	2022	How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.	NOTCH1
35279479	10.1016/j.imbio.2022.152205	2022	Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.	NOTCH1
35280829	10.3389/fonc.2022.811151	2022	Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing.	NOTCH1
35280868	10.3389/fmed.2022.826705	2022	Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring <i>EML4-ALK</i> Fusion Gene: Study of Two Typical Cases and Review of Literature.	NOTCH1
35300216	10.2147/JIR.S341355	2022	The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma.	NOTCH1
35401501	10.3389/fimmu.2022.867443	2022	Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
35589701	10.1038/s41467-022-30396-3	2022	Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.	NOTCH1
35592856	10.3389/fmed.2022.808378	2022	A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.	NOTCH1
35605191	10.1182/blood.2021015144	2022	NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness.	NOTCH1
35680792	10.19746/j.cnki.issn.1009-2137.2022.03.006	2022	[Effect of Curcumin on Apoptosis of Acute T-Lymphoblastic Leukemia Cells induced by UMI-77 and Its Related Mechanism].	NOTCH1
35681778	10.3390/cancers14112799	2022	The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas.	NOTCH1
35685993	10.21147/j.issn.1000-9604.2022.02.03	2022	Genomic landscape of T-cell lymphoblastic lymphoma.	NOTCH1
35734596	10.3389/fonc.2022.846573	2022	The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China.	NOTCH1
35767640	10.1073/pnas.2118529119	2022	Early expression of mature αβ TCR in CD4<sup>-</sup>CD8<sup>-</sup> T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.	NOTCH1
35768390	10.3760/cma.j.cn112137-20211025-02358	2022	[Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].	NOTCH1
35774848	10.1155/2022/3276925	2022	Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.	NOTCH1
35829664	10.1111/bjh.18352	2022	Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.	NOTCH1
35852337	10.1128/spectrum.01478-22	2022	BET-Independent Murine Leukemia Virus Integration Is Retargeted <i>In Vivo</i> and Selects Distinct Genomic Elements for Lymphomagenesis.	NOTCH1
35910501	10.6004/jadpro.2022.13.5.7	2022	An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia.	NOTCH1
35915142	10.1038/s41375-022-01651-9	2022	Inhibition of the m<sup>6</sup>A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia.	NOTCH1
36000950	10.1002/pbc.29926	2022	Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.	NOTCH1
36090975	10.3389/fimmu.2022.987298	2022	Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.	NOTCH1
32273478	10.3324/haematol.2020.251579	2021	Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.	NOTCH1
32327503	10.3324/haematol.2019.238766	2021	Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.	NOTCH1
32382081	10.1038/s41375-020-0845-6	2021	SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia.	NOTCH1
32415821	10.17305/bjbms.2020.4687	2021	Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review.	NOTCH1
32733009	10.1038/s41375-020-0999-2	2021	Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination.	NOTCH1
32812017	10.1182/blood.2020006996	2021	Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.	NOTCH1
33068240	10.1007/s11845-020-02386-1	2021	Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias.	NOTCH1
33152759	10.1182/blood.2020005381	2021	Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.	NOTCH1
33191568	10.1002/onco.13595	2021	More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.	NOTCH1
33227818	10.1182/blood.2019004547	2021	Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.	NOTCH1
33310759	10.26508/lsa.202000794	2021	Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.	NOTCH1
33314742	10.1002/1878-0261.12877	2021	Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.	NOTCH1
33316538	10.1016/j.neo.2020.11.010	2021	U-RT1 - A new model for Richter transformation.	NOTCH1
33407740	10.1186/s13045-020-01015-9	2021	Targeting oncogenic Notch signaling with SERCA inhibitors.	NOTCH1
33436855	10.1038/s41598-020-80613-6	2021	Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.	NOTCH1
33458694	10.1158/2643-3230.BCD-20-0201	2021	A Tumor Suppressor Enhancer of <i>PTEN</i> in T-cell development and leukemia.	NOTCH1
33479306	10.1038/s41598-020-80376-0	2021	Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.	NOTCH1
33526873	10.1038/s41379-021-00739-4	2021	Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.	NOTCH1
33538669	10.2174/1389450122666210203192752	2021	Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia.	NOTCH1
33538798	10.1182/blood.2020005734	2021	Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.	NOTCH1
33569430	10.21037/atm-20-7574	2021	Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity.	NOTCH1
33570635	10.1182/bloodadvances.2020002995	2021	Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.	NOTCH1
33571115	10.1126/sciadv.abc9781	2021	NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia.	NOTCH1
33578108	10.1016/j.jbior.2021.100788	2021	Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.	NOTCH1
33611795	10.1002/gcc.22943	2021	MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.	NOTCH1
33615197	10.1016/j.isci.2021.102089	2021	Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways.	NOTCH1
33634864	10.1002/ijc.33527	2021	Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis.	NOTCH1
33775465	10.1016/j.blre.2021.100824	2021	Revisiting Richter transformation in the era of novel CLL agents.	NOTCH1
33777778	10.3389/fonc.2021.628807	2021	Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.	NOTCH1
33858050	10.3760/cma.j.issn.0253-2727.2021.02.014	2021	[The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].	NOTCH1
33876224	10.1182/blood.2020008955	2021	A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia.	NOTCH1
33925883	10.3390/ijms22094502	2021	The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
33941203	10.1186/s13045-021-01068-4	2021	Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.	NOTCH1
33942287	10.1111/bjh.17310	2021	Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.	NOTCH1
33947863	10.1038/s41467-021-22787-9	2021	Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures.	NOTCH1
33972504	10.1038/s41408-021-00477-5	2021	Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.	NOTCH1
34035082	10.1158/0008-5472.CAN-20-2823	2021	Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.	NOTCH1
34080325	10.1002/cam4.4024	2021	The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.	NOTCH1
34167562	10.1186/s13045-021-01114-1	2021	PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia.	NOTCH1
34188174	10.1038/s42003-021-02330-8	2021	NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia.	NOTCH1
34203994	10.3390/cancers13123005	2021	<i>DLX</i> Genes: Roles in Development and Cancer.	NOTCH1
34218589	10.3760/cma.j.issn.0253-2727.2021.05.015	2021	[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].	NOTCH1
34223928	10.1007/s00109-021-02101-2	2021	CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.	NOTCH1
34256839	10.1186/s40164-021-00232-3	2021	Progress in molecular feature of smoldering mantle cell lymphoma.	NOTCH1
34376672	10.1038/s41467-021-25101-9	2021	Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.	NOTCH1
34407842	10.1186/s13046-021-02071-w	2021	SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression.	NOTCH1
34440292	10.3390/genes12081118	2021	T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.	NOTCH1
34506616	10.1371/journal.pone.0257353	2021	Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).	NOTCH1
34514345	10.1097/HS9.0000000000000641	2021	Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and <i>NOTCH1/FBXW7</i> Status.	NOTCH1
34573936	10.3390/diagnostics11091594	2021	Prognostic Role of Minimal Disseminated Disease and <i>NOTCH1/FBXW7</i> Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.	NOTCH1
34680290	10.3390/cancers13205141	2021	Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.	NOTCH1
34698884	10.1007/s00018-021-03979-4	2021	MicroRNA-34a: the bad guy in age-related vascular diseases.	NOTCH1
34735923	10.1016/j.imbio.2021.152149	2021	Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia.	NOTCH1
34739844	10.1016/j.ccell.2021.10.006	2021	Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.	NOTCH1
34753401	10.1080/16078454.2021.1997197	2021	Circ_0000745 regulates NOTCH1-mediated cell proliferation and apoptosis in pediatric T-cell acute lymphoblastic leukemia through adsorbing miR-193b-3p.	NOTCH1
34771656	10.3390/cancers13215493	2021	High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in Mice.	NOTCH1
34956871	10.3389/fonc.2021.746577	2021	Clinical Features and Prognostic Significance of <i>NOTCH1</i> Mutations in Diffuse Large B-Cell Lymphoma.	NOTCH1
34956898	10.3389/fonc.2021.780085	2021	Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features.	NOTCH1
35008340	10.3390/cancers14010176	2021	Recent Advances in the Genetic of MALT Lymphomas.	NOTCH1
35111674	10.3389/fonc.2021.790481	2021	Mutations in <i>JAK/STAT</i> and <i>NOTCH1</i> Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders.	NOTCH1
29313423	10.1080/21541248.2018.1423851	2020	Rho guanosine nucleotide exchange factors are not such bad guys after all in cancer<sup>a</sup>.	NOTCH1
31467126	10.3324/haematol.2019.217687	2020	Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts.	NOTCH1
31570389	10.1101/cshperspect.a035246	2020	The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
31586130	10.1038/s41388-019-1042-9	2020	NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling.	NOTCH1
31739126	10.1016/j.cancergen.2019.11.002	2020	Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.	NOTCH1
31785807	10.1016/j.bbrc.2019.11.148	2020	Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.	NOTCH1
31796666	10.3233/CBM-190967	2020	Significance of NOTCH1 mutations détections in T-acute lymphoblastic leukemia patients.	NOTCH1
31804006	10.1002/cam4.2757	2020	RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.	NOTCH1
31822496	10.1158/0008-5472.CAN-19-1471	2020	ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.	NOTCH1
31852326	10.1080/08880018.2019.1701160	2020	Mutation analysis in Korean patients with T-cell acute lymphoblastic leukemia.	NOTCH1
31853322	10.3892/etm.2019.8228	2020	miR-9 inhibition of neuronal apoptosis and expression levels of apoptosis genes Bcl-2 and Bax in depression model rats through Notch pathway.	NOTCH1
31894255	10.3892/ijmm.2019.4418	2020	Precision medicine for human cancers with Notch signaling dysregulation (Review).	NOTCH1
31930426	10.2340/00015555-3402	2020	Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides.	NOTCH1
32027255	10.19746/j.cnki.issn.1009-2137.2020.01.012	2020	[Analysis of Clinical Characteristics and Therapeutic Efficacy of Patients with Adult Acute Lymphoblastic Leukemia].	NOTCH1
32080345	10.1038/s41375-020-0757-5	2020	A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study.	NOTCH1
32143838	10.1016/j.cellimm.2020.104081	2020	NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.	NOTCH1
32160292	10.1182/blood.2019002385	2020	Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.	NOTCH1
32164600	10.1186/s12885-020-6709-7	2020	Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing.	NOTCH1
32173361	10.1016/j.exphem.2020.03.001	2020	Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.	NOTCH1
32179411	10.1016/j.bcmd.2020.102419	2020	PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India.	NOTCH1
32185137	10.3389/fonc.2020.00273	2020	The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects.	NOTCH1
32187361	10.1182/blood.2019003535	2020	Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.	NOTCH1
32191807	10.1182/bloodadvances.2019001396	2020	Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.	NOTCH1
32234760	10.1158/1078-0432.CCR-19-4207	2020	A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma.	NOTCH1
32245383	10.1186/s12920-020-0709-y	2020	Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.	NOTCH1
32272636	10.3390/cancers12040894	2020	An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy.	NOTCH1
32277542	10.1002/gcc.22849	2020	Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.	NOTCH1
32277947	10.1016/j.taap.2020.115001	2020	Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.	NOTCH1
32317694	10.1038/s41598-020-63434-5	2020	Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.	NOTCH1
32386594	10.1016/j.chembiol.2020.04.002	2020	Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.	NOTCH1
32431543	10.2147/CMAR.S242903	2020	Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population.	NOTCH1
32432760	10.26355/eurrev_202005_21188	2020	MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway.	NOTCH1
32432776	10.26355/eurrev_202005_21205	2020	Effect of atorvastatin on pulmonary hypertension rats through regulating notch signaling pathway.	NOTCH1
32487610	10.21873/anticanres.14297	2020	Sirtuin 1 Activation Suppresses the Growth of T-lymphoblastic Leukemia Cells by Inhibiting NOTCH and NF-κB Pathways.	NOTCH1
32526730		2020	T-Cell Acute Lymphoblastic Leukemia: A Cytogenomic Update.	NOTCH1
32604737	10.3390/microorganisms8060958	2020	Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein-Barr in Pediatric Patients.	NOTCH1
32651260	10.1158/0008-5472.CAN-20-0034	2020	Monocyte-Derived Leukemia-Associated Macrophages Facilitate Extramedullary Distribution of T-cell Acute Lymphoblastic Leukemia Cells.	NOTCH1
32677544	10.1080/15384101.2020.1792686	2020	A Gli inhibitor GANT61 suppresses cell proliferation, promotes cell apoptosis and induces G1/G0 cycle retardation with a dose- and time-dependent manner through inhibiting Notch pathway in multiple myeloma.	NOTCH1
32695399	10.1186/s40364-020-00205-4	2020	Plasma circulating tumor DNA assessment reveals <i>KMT2D</i> as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.	NOTCH1
32708470	10.3390/cells9071726	2020	miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
32732220	10.1158/0008-5472.CAN-20-0486	2020	Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.	NOTCH1
32738175	10.1002/hon.2784	2020	Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.	NOTCH1
32793890	10.1158/0008-5472.BCD-19-0041	2020	Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.	NOTCH1
32828943	10.1016/j.lfs.2020.118306	2020	Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway.	NOTCH1
32848129	10.1038/s41408-020-00351-w	2020	Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.	NOTCH1
32894532	10.26355/eurrev_202008_22622	2020	MiR-145 targeting BNIP3 reduces apoptosis of chondrocytes in osteoarthritis through Notch signaling pathway.	NOTCH1
32907612	10.1186/s12943-020-01254-x	2020	Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.	NOTCH1
32918521	10.1002/pbc.28704	2020	Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia.	NOTCH1
32924017	10.1158/2643-3230.BCD-20-0026	2020	Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemia.	NOTCH1
32939265	10.1186/s40364-020-00222-3	2020	Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.	NOTCH1
32963611	10.3892/ol.2020.12068	2020	Mutational analysis of extranodal marginal zone lymphoma using next generation sequencing.	NOTCH1
33010698	10.1016/j.prp.2020.153212	2020	LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway.	NOTCH1
33017398	10.1371/journal.pbio.3000850	2020	Notch dimerization and gene dosage are important for normal heart development, intestinal stem cell maintenance, and splenic marginal zone B-cell homeostasis during mite infestation.	NOTCH1
33072583	10.3389/fonc.2020.558339	2020	MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation.	NOTCH1
33283700	10.19746/j.cnki.issn.1009-2137.2020.06.001	2020	[Gene Mutation in Acute Lymphoblastic Leukemia by DNA Sequencing].	NOTCH1
33585446	10.3389/fcell.2020.606448	2020	Vascular Notch Signaling in Stress Hematopoiesis.	NOTCH1
34865381	10.3760/cma.j.cn112138-20190924-00652	2020	[Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].	NOTCH1
30224339	10.1158/1078-0432.CCR-18-0867	2019	NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263.	NOTCH1
30280491	10.1002/pbc.27496	2019	Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.	NOTCH1
30365070	10.3892/ijmm.2018.3957	2019	MicroRNA-98 reduces amyloid β-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice.	NOTCH1
30370525	10.1002/jcp.27323	2019	Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.	NOTCH1
30387229	10.1111/cas.13859	2019	NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.	NOTCH1
30431086	10.3892/mmr.2018.9637	2019	Activation of the Notch‑Nox4‑reactive oxygen species signaling pathway induces cell death in high glucose‑treated human retinal endothelial cells.	NOTCH1
30467824	10.14670/HH-18-067	2019	Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient.	NOTCH1
30482776	10.1158/0008-5472.CAN-18-1987	2019	Ribosomal Lesions Promote Oncogenic Mutagenesis.	NOTCH1
30514801	10.3324/haematol.2018.198424	2019	T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.	NOTCH1
30563887	10.1158/0008-5472.CAN-18-1617	2019	Inhibition of Notch Signaling Enhances Chemosensitivity in B-cell Precursor Acute Lymphoblastic Leukemia.	NOTCH1
30567843	10.1158/2159-8290.CD-18-1005	2019	<i>Phf6</i> Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL.	NOTCH1
30578688	10.1002/gcc.22723	2019	CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia.	NOTCH1
30635552	10.1038/s12276-018-0195-x	2019	CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.	NOTCH1
30718223	10.1016/j.anndiagpath.2019.01.004	2019	The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.	NOTCH1
30721949	10.1093/carcin/bgz013	2019	Mutational landscape of T-cell lymphoma in mice lacking the DNA mismatch repair gene Mlh1: no synergism with ionizing radiation.	NOTCH1
30734052	10.2340/00015555-3141	2019	Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.	NOTCH1
30777096	10.1186/s13046-019-1076-4	2019	Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.	NOTCH1
30839226	10.1089/dna.2018.4396	2019	Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.	NOTCH1
30914196	10.1016/j.bbrc.2019.03.094	2019	Activation of Notch1 signaling by HTLV-1 Tax promotes proliferation of adult T-cell leukemia cells.	NOTCH1
30940846	10.1038/s41598-019-41805-x	2019	Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice.	NOTCH1
30950667	10.1080/10428194.2019.1597270	2019	Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia.	NOTCH1
30953029	10.1038/s41375-019-0466-0	2019	Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.	NOTCH1
30967635	10.1038/s41388-019-0802-x	2019	The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition.	NOTCH1
31023700	10.1182/blood.2018882555	2019	Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.	NOTCH1
31132650	10.1016/j.anndiagpath.2019.05.004	2019	TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.	NOTCH1
31142678	10.1126/scitranslmed.aau6246	2019	Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition.	NOTCH1
31226848	10.3390/ijms20123021	2019	Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
31285322	10.1073/pnas.1905305116	2019	Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.	NOTCH1
31298359	10.26355/eurrev_201906_18168	2019	MiR-9 facilitates cartilage regeneration of osteoarthritis in rabbits through regulating Notch signaling pathway.	NOTCH1
31308913	10.4084/MJHID.2019.037	2019	Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies.	NOTCH1
31311407	10.1080/15384047.2019.1638670	2019	Somatic mutations in <i>KMT2D</i> and <i>TET2</i> associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.	NOTCH1
31322185	10.3892/mmr.2019.10451	2019	miR‑338‑3p suppresses the malignancy of T‑cell lymphoblastic lymphoma by downregulating HOXA3.	NOTCH1
31344256	10.1111/bjh.16117	2019	The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.	NOTCH1
31346528	10.1155/2019/5601396	2019	Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.	NOTCH1
31399482	10.1242/dmm.040931	2019	Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia.	NOTCH1
31476403	10.1016/j.gene.2019.144095	2019	Penehyclidine hydrochloride defends against LPS-induced ALI in rats by mitigating endoplasmic reticulum stress and promoting the Hes1/Notch1 pathway.	NOTCH1
31530562	10.1182/blood.2019000982	2019	IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.	NOTCH1
31543360	10.1016/j.jbior.2019.100652	2019	Insulin-like growth factor (IGF) signaling in T-cell acute lymphoblastic leukemia.	NOTCH1
31622281	10.1172/jci.insight.131434	2019	A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.	NOTCH1
31655559	10.1186/s12885-019-6209-9	2019	The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.	NOTCH1
31676012	10.1186/s13046-019-1458-7	2019	Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.	NOTCH1
31690634	10.1126/scisignal.aay2369	2019	Extension of the Notch intracellular domain ankyrin repeat stack by NRARP promotes feedback inhibition of Notch signaling.	NOTCH1
31712410	10.1073/pnas.1913919116	2019	Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.	NOTCH1
31717324	10.3390/cancers11111755	2019	The Role of Nrf2 Activity in Cancer Development and Progression.	NOTCH1
31752447	10.3390/cancers11111820	2019	Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications.	NOTCH1
31799679	10.26355/eurrev_201911_19576	2019	Effect of lncRNA GAS5 on the apoptosis of neurons via the notch1 signaling pathway in rats with cerebral infarction.	NOTCH1
31819653	10.2147/CMAR.S232075	2019	CircCDYL Serves as a New Biomarker in Mantle Cell Lymphoma and Promotes Cell Proliferation.	NOTCH1
31824864	10.3389/fonc.2019.01304	2019	Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying <i>RUNX1</i> and <i>NOTCH1</i> Gene Mutations.	NOTCH1
35117001	10.21037/tcr.2019.10.04	2019	Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.	NOTCH1
28776427	10.1080/10428194.2017.1359742	2018	ETV6 and NOTCH1 germline variants in adult acute leukemia.	NOTCH1
28914259	10.1038/leu.2017.282	2018	Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.	NOTCH1
28925785	10.1080/10428194.2017.1376746	2018	Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.	NOTCH1
29051182	10.1182/blood-2017-04-778829	2018	Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.	NOTCH1
29115891	10.1080/10428194.2017.1397660	2018	The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.	NOTCH1
29151585	10.1038/leu.2017.328	2018	Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.	NOTCH1
29158376	10.1084/jem.20151778	2018	Leukemia-specific delivery of mutant NOTCH1 targeted therapy.	NOTCH1
29180399	10.1182/blood-2017-09-805663	2018	Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.	NOTCH1
29200162	10.1097/MPH.0000000000001006	2018	Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.	NOTCH1
29330145	10.1158/0008-5472.CAN-17-1434	2018	MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL.	NOTCH1
29342136	10.1038/nature25186	2018	Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.	NOTCH1
29382756	10.1073/pnas.1716452115	2018	Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.	NOTCH1
29484684	10.1002/hon.2502	2018	Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.	NOTCH1
29514083	10.1016/j.celrep.2018.02.049	2018	PI3K/Akt Cooperates with Oncogenic Notch by Inducing Nitric Oxide-Dependent Inflammation.	NOTCH1
29556024	10.1038/s41375-018-0046-8	2018	The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.	NOTCH1
29599840	10.3892/etm.2018.5784	2018	Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1/c-Myc signaling in T-cell lymphoma cells.	NOTCH1
29641966	10.1056/NEJMoa1801445	2018	Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.	NOTCH1
29643474	10.1038/s41388-018-0234-z	2018	Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.	NOTCH1
29654263	10.1038/s41375-018-0097-x	2018	Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.	NOTCH1
29666622	10.3389/fimmu.2018.00633	2018	Chemotactic Cues for NOTCH1-Dependent Leukemia.	NOTCH1
29674500	10.3324/haematol.2018.191601	2018	Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites.	NOTCH1
29692342	10.1182/blood-2018-01-791376	2018	Biology and treatment of Richter syndrome.	NOTCH1
29725418	10.3892/ol.2018.8193	2018	Differential regulation of AKT1 contributes to survival and proliferation in hepatocellular carcinoma cells by mediating Notch1 expression.	NOTCH1
29733873	10.1016/j.exphem.2018.04.008	2018	RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.	NOTCH1
29735551	10.1158/0008-5472.CAN-17-4004	2018	Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.	NOTCH1
29740158	10.1038/s41375-018-0127-8	2018	Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.	NOTCH1
29765142	10.1038/s41379-018-0064-0	2018	Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.	NOTCH1
29781813	10.1172/JCI92981	2018	The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.	NOTCH1
29845231	10.3892/mmr.2018.9029	2018	Identification of key gene networks associated with fracture healing using αSMA‑labeled progenitor cells.	NOTCH1
29877249	10.11406/rinketsu.59.574	2018	[The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL].	NOTCH1
29908894	10.1016/j.brainresbull.2018.06.005	2018	MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.	NOTCH1
29938780	10.1111/bjh.15449	2018	The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.	NOTCH1
29948644	10.1007/s11899-018-0455-9	2018	Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.	NOTCH1
29976660	10.1128/JVI.00580-18	2018	Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.	NOTCH1
29989027	10.18632/oncotarget.25601	2018	New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.	NOTCH1
30030836	10.1007/978-3-319-89512-3_18	2018	Notch in Leukemia.	NOTCH1
30032036	10.1016/j.neo.2018.07.001	2018	Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma.	NOTCH1
30038221	10.1038/s41591-018-0105-8	2018	Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia.	NOTCH1
30103821	10.1186/s13104-018-3700-3	2018	FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells.	NOTCH1
30111389	10.7534/j.issn.1009-2137.2018.04.001	2018	[Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia].	NOTCH1
30116272	10.1186/s11658-018-0102-4	2018	The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells.	NOTCH1
30208327	10.1016/j.celrep.2018.08.030	2018	STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia.	NOTCH1
30213787	10.1182/bloodadvances.2018019919	2018	B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.	NOTCH1
30231940	10.1186/s13045-018-0665-6	2018	JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells.	NOTCH1
30250888	10.1080/23723556.2018.1432257	2018	An unexpected tumor suppressor role for VAV1<sup>a</sup>.	NOTCH1
30266814	10.1158/2159-8290.CD-17-0831	2018	Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.	NOTCH1
30269902	10.1016/j.stem.2018.08.018	2018	Epigenetic Restoration of Fetal-like IGF1 Signaling Inhibits Leukemia Stem Cell Activity.	NOTCH1
30295241	10.7534/j.issn.1009-2137.2018.05.007	2018	[Effect of FBXW7 and NOTCH1 Mutations on Prognosis of Patients with Adult Acute T Lymphoblastic Leukemia].	NOTCH1
30370255	10.15430/JCP.2018.23.3.109	2018	PIM Kinase as an Executional Target in Cancer.	NOTCH1
30466748	10.1016/j.beha.2018.10.001	2018	Can one target T-cell ALL?	NOTCH1
30574752		2018	miR-200b promotes cell proliferation and invasion in t-cell acute Lymphoblastic leukemia through NOTCH1.	NOTCH1
30788923	10.12047/j.cjap.5674.2018.097	2018	[Effects of irbesartan on Notch1 signaling pathway in diabetic rats with myocardial injury].	NOTCH1
27181628	10.1080/10428194.2016.1180681	2017	Chemotherapeutic treatment is associated with Notch1 induction in cutaneous T-cell lymphoma.	NOTCH1
27499002	10.1080/10428194.2016.1213829	2017	Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.	NOTCH1
27686521	10.1080/10428194.2016.1211278	2017	NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.	NOTCH1
27730468	10.1007/s12015-016-9691-3	2017	Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.	NOTCH1
27758824	10.3324/haematol.2016.154013	2017	CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells.	NOTCH1
27759908	10.1002/pbc.26266	2017	Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.	NOTCH1
27872496	10.1038/leu.2016.339	2017	Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.	NOTCH1
27872499	10.1038/leu.2016.340	2017	Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia.	NOTCH1
27888718	10.1016/j.molimm.2016.11.014	2017	Characterization of peritoneal leukemia-associated macrophages in Notch1-induced mouse T cell acute lymphoblastic leukemia.	NOTCH1
27936980	10.1080/17474086.2017.1270203	2017	Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.	NOTCH1
28004113	10.3892/or.2016.5281	2017	Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53.	NOTCH1
28096536	10.1038/leu.2017.25	2017	Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia.	NOTCH1
28115368	10.1182/blood-2016-09-692582	2017	The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.	NOTCH1
28115373	10.1182/blood-2016-10-706465	2017	The genetics and molecular biology of T-ALL.	NOTCH1
28122332	10.18632/oncotarget.14784	2017	The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.	NOTCH1
28143869	10.1158/1078-0432.CCR-16-2880	2017	Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis.	NOTCH1
28151717	10.1158/1078-0432.CCR-15-2869	2017	Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.	NOTCH1
28157189	10.1038/bcj.2016.122	2017	Identification of cell-type-specific mutations in nodal T-cell lymphomas.	NOTCH1
28174276	10.1073/pnas.1611831114	2017	Synergistic antileukemic therapies in <i>NOTCH1</i>-induced T-ALL.	NOTCH1
28245838	10.1186/s13045-017-0431-1	2017	Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.	NOTCH1
28314854	10.1073/pnas.1702564114	2017	Common nonmutational <i>NOTCH1</i> activation in chronic lymphocytic leukemia.	NOTCH1
28321121	10.1038/leu.2017.89	2017	Dnmt3a regulates T-cell development and suppresses T-ALL transformation.	NOTCH1
28359267	10.1186/s12885-017-3233-5	2017	Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.	NOTCH1
28360149	10.3324/haematol.2016.157792	2017	<i>NOTCH1</i> mutation, <i>TP53</i> alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.	NOTCH1
28446316	10.7534/j.issn.1009-2137.2017.02.050	2017	[Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].	NOTCH1
28487945	10.3892/mmr.2017.6516	2017	Nox4 is involved in high glucose-induced apoptosis in renal tubular epithelial cells via Notch pathway.	NOTCH1
28505169	10.1371/journal.pone.0177524	2017	Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.	NOTCH1
28664939	10.1038/modpathol.2017.58	2017	Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.	NOTCH1
28671688	10.1038/ng.3909	2017	The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.	NOTCH1
28716817	10.1158/1535-7163.MCT-17-0141	2017	PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.	NOTCH1
28747286	10.4274/tjh.2017.0194	2017	Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.	NOTCH1
28790107	10.1182/blood-2017-03-775536	2017	RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemia.	NOTCH1
28819011	10.1182/blood-2017-04-779736	2017	<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.	NOTCH1
28827447	10.1084/jem.20170167	2017	Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.	NOTCH1
28870926	10.21873/anticanres.11914	2017	Hedgehog Stimulation Suppresses Clonogenicity and Activates NOTCH Signalling in T-lymphoblastic Leukaemia Jurkat Cells.	NOTCH1
28892521	10.1371/journal.pone.0183969	2017	A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.	NOTCH1
29023469	10.1371/journal.pone.0185762	2017	The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.	NOTCH1
29045517	10.1093/annonc/mdx407	2017	Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.	NOTCH1
29136506	10.1016/j.ccell.2017.10.004	2017	A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.	NOTCH1
29138297	10.1126/scisignal.aam6846	2017	MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.	NOTCH1
29246179	10.1186/s13046-017-0652-8	2017	Smoldering mantle cell lymphoma.	NOTCH1
31966505		2017	Curcumin combined with cis-platinum promote the apoptosis of human colorectal cancer HT29 cells and mechanism.	NOTCH1
26220040	10.1038/leu.2015.206	2016	Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.	NOTCH1
26239199	10.1038/leu.2015.210	2016	Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow.	NOTCH1
26292904	10.3109/10428194.2015.1080366	2016	Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia.	NOTCH1
26426381	10.1097/PAS.0000000000000523	2016	NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.	NOTCH1
26589915	10.3324/haematol.2015.137695	2016	FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.	NOTCH1
26644537	10.1200/JCO.2015.61.5385	2016	Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.	NOTCH1
26707936	10.1038/leu.2015.353	2016	CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.	NOTCH1
26753883	10.1038/ncomms10087	2016	Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.	NOTCH1
26787889	10.1073/pnas.1525354113	2016	Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice.	NOTCH1
26797410	10.1136/jclinpath-2015-203403	2016	Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.	NOTCH1
26801976	10.1158/0008-5472.CAN-15-2092	2016	Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.	NOTCH1
26816546	10.1111/1759-7714.12297	2016	Notch1 controls cell chemoresistance in small cell lung carcinoma cells.	NOTCH1
26821066	10.1038/cddis.2015.413	2016	The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling.	NOTCH1
26864725	10.1080/15384101.2015.1128191	2016	Targeting NOTCH1 in T-ALL: Starving the dragon.	NOTCH1
26931577	10.1189/jlb.5MA0915-394R	2016	Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.	NOTCH1
26934331	10.18632/oncotarget.7772	2016	Notch signaling: its roles and therapeutic potential in hematological malignancies.	NOTCH1
26985716	10.3892/ijmm.2016.2525	2016	Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.	NOTCH1
27040710	10.1053/j.seminoncol.2016.02.012	2016	Richter syndrome: pathogenesis and management.	NOTCH1
27070758	10.1016/j.leukres.2016.03.002	2016	Risk stratification of T-cell Acute Lymphoblastic Leukemia patients based on gene expression, mutations and copy number variation.	NOTCH1
27121112	10.3109/10428194.2016.1173212	2016	Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.	NOTCH1
27125305	10.1038/leu.2016.106	2016	β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.	NOTCH1
27151993	10.3324/haematol.2015.139410	2016	RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.	NOTCH1
27157619	10.1038/onc.2016.133	2016	Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.	NOTCH1
27206675	10.18632/oncotarget.9390	2016	Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL.	NOTCH1
27229929	10.1186/s12885-016-2374-2	2016	Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.	NOTCH1
27235137	10.1182/blood-2016-02-700328	2016	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	NOTCH1
27247421	10.1073/pnas.1601537113	2016	Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.	NOTCH1
27342483	10.7534/j.issn.1009-2137.2016.03.001	2016	[Effect of PDK1 on Notch1-Induced Mouse T-cell Acute Lymphoblastic Leukemia].	NOTCH1
27342484	10.7534/j.issn.1009-2137.2016.03.002	2016	[ADAR1 Knockout Inhibits Notch1-induced T-ALL in Mice].	NOTCH1
27351634	10.1080/17474086.2016.1199948	2016	Richter transformation of CLL.	NOTCH1
27391576	10.1038/bcj.2016.57	2016	Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice.	NOTCH1
27449094	10.18632/oncotarget.10716	2016	Gene mutations and actionable genetic lesions in mantle cell lymphoma.	NOTCH1
27451956	10.1038/nrc.2016.63	2016	The genetics and mechanisms of T cell acute lymphoblastic leukaemia.	NOTCH1
27473087	10.1007/s13277-016-5272-y	2016	Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.	NOTCH1
27531766	10.7534/j.issn.1009-2137.2016.04.010	2016	[Mutation of IL-7R in Adult Patients with T-cell Acute Lymphoblastic Leukemia and Its Clinical Significance].	NOTCH1
27566587	10.18632/oncotarget.11548	2016	Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.	NOTCH1
27582570	10.3324/haematol.2016.146381	2016	The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.	NOTCH1
27602765	10.18632/oncotarget.11796	2016	Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.	NOTCH1
27612641	10.1016/j.immuni.2016.07.018	2016	Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease.	NOTCH1
27666896	10.3892/or.2016.5117	2016	MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.	NOTCH1
27670423	10.1182/blood-2016-01-692855	2016	High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.	NOTCH1
27742070	10.1016/j.beha.2016.08.006	2016	Richter's syndrome: Novel and promising therapeutic alternatives.	NOTCH1
27797342	10.1172/JCI86489	2016	High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.	NOTCH1
27900092	10.3892/mco.2016.1008	2016	Primary orbital precursor T-cell lymphoblastic lymphoma: Report of a unique case.	NOTCH1
24844362	10.3109/10428194.2014.917638	2015	Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia.	NOTCH1
25118879	10.1038/leu.2014.241	2015	Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.	NOTCH1
25248094	10.5858/arpa.2014-0086-RA	2015	Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.	NOTCH1
25281505	10.3324/haematol.2014.110742	2015	Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.	NOTCH1
25311243	10.1038/leu.2014.302	2015	A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.	NOTCH1
25355291	10.1093/carcin/bgu223	2015	DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.	NOTCH1
25371176	10.1038/leu.2014.315	2015	Wild-type KRAS inhibits oncogenic KRAS-induced T-ALL in mice.	NOTCH1
25371178	10.1038/leu.2014.318	2015	The impact of SF3B1 mutations in CLL on the DNA-damage response.	NOTCH1
25381127	10.3324/haematol.2014.116855	2015	The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.	NOTCH1
25393162	10.1002/cyto.a.22582	2015	Notch affects the prodifferentiating effect of retinoic acid and PMA on leukemic cells.	NOTCH1
25412322	10.3892/mmr.2014.2976	2015	Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.	NOTCH1
25493453	10.1097/MPH.0000000000000290	2015	NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.	NOTCH1
25502893	10.1097/MOP.0000000000000171	2015	Update on biology and treatment of T-cell acute lymphoblastic leukaemia.	NOTCH1
25517959	10.1097/PAS.0000000000000358	2015	NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.	NOTCH1
25582697	10.1158/2159-8290.CD-14-0625	2015	PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.	NOTCH1
25584678	10.4161/15384101.2014.989129	2015	An oncogenic enhancer enemy (N-Me) in T-ALL.	NOTCH1
25595890	10.18632/oncotarget.2218	2015	Mutational spectrum of adult T-ALL.	NOTCH1
25637217	10.1016/j.yexcr.2015.01.008	2015	Role of stromal cells-mediated Notch-1 in the invasion of T-ALL cells.	NOTCH1
25644173	10.1186/s12943-014-0285-x	2015	Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.	NOTCH1
25655195	10.1038/leu.2015.27	2015	Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.	NOTCH1
25662994	10.4049/jimmunol.1400451	2015	Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia.	NOTCH1
25663545	10.1007/s10549-015-3279-5	2015	The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.	NOTCH1
25671302	10.18632/oncotarget.3244	2015	Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.	NOTCH1
25700513	10.1126/science.1261093	2015	Structural biology. Structural basis for Notch1 engagement of Delta-like 4.	NOTCH1
25710912	10.4049/jimmunol.1402443	2015	Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway.	NOTCH1
25721902	10.3109/10428194.2015.1023800	2015	Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.	NOTCH1
25740104	10.3324/haematol.2014.118562	2015	T-ALL: ALL a matter of Translation?	NOTCH1
25784680	10.1182/blood-2014-10-608448	2015	Therapeutic targeting of HES1 transcriptional programs in T-ALL.	NOTCH1
25860243	10.3109/10428194.2015.1028051	2015	Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.	NOTCH1
25879451	10.18632/oncotarget.3621	2015	Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.	NOTCH1
25903014	10.1186/s13045-015-0138-0	2015	Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.	NOTCH1
25930743	10.1002/gcc.22252	2015	Unique clonal relationship between T-cell acute lymphoblastic leukemia and subsequent Langerhans cell histiocytosis with TCR rearrangement and NOTCH1 mutation.	NOTCH1
25942645	10.1371/journal.pone.0125429	2015	Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.	NOTCH1
25966987	10.1182/blood-2014-10-551895	2015	How I treat T-cell acute lymphoblastic leukemia in adults.	NOTCH1
26002977	10.4049/jimmunol.1402639	2015	Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.	NOTCH1
26018266		2015	[Triptolide induces apoptosis of human acute T lymphocytic leukemia Jurkat cells via inhibiting transcription of human endogenous retrovirus HERV-K Np9 gene].	NOTCH1
26046801	10.1038/srep11012	2015	A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.	NOTCH1
26056302	10.1073/pnas.1424104112	2015	Disregulated expression of the transcription factor ThPOK during T-cell development leads to high incidence of T-cell lymphomas.	NOTCH1
26058076	10.1016/j.ccell.2015.05.003	2015	CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.	NOTCH1
26077240	10.1200/JCO.2014.60.6327	2015	Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.	NOTCH1
26108691	10.1038/leu.2015.162	2015	Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.	NOTCH1
26117003	10.7534/j.issn.1009-2137.2015.03.002	2015	[Mutations of FBXW7 in Adult T-Cell Acute Lymphocytic Leukemia].	NOTCH1
26117016	10.7534/j.issn.1009-2137.2015.03.015	2015	[Effects of Silencing AKT Gene by shRNA on Proliferation, Apoptosis and Notch1 Signal Pathway in Jeko-1 Cells].	NOTCH1
26125582	10.1371/journal.pone.0130666	2015	Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy.	NOTCH1
26160878	10.3324/haematol.2015.127498	2015	Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.	NOTCH1
26205622	10.1111/bjh.13613	2015	Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.	NOTCH1
26206799	10.3324/haematol.2015.130179	2015	Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.	NOTCH1
26229090	10.1158/2159-8290.CD-15-0370	2015	Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.	NOTCH1
26302069	10.1038/jid.2015.328	2015	Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides.	NOTCH1
26314424	10.7534/j.issn.1009-2137.2015.04.008	2015	[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Acute T-Lymphoblastic Leukemia Jurkat Cells In Vitro and Its Possible Mechanisms].	NOTCH1
26330272	10.1038/srep13749	2015	LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia.	NOTCH1
26341754	10.1007/s00277-015-2474-0	2015	Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.	NOTCH1
26365182	10.1016/j.celrep.2015.08.034	2015	Off-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus.	NOTCH1
26390244	10.1038/nm.3955	2015	Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.	NOTCH1
26407235	10.1038/bcj.2015.80	2015	A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.	NOTCH1
26450156	10.1186/s12885-015-1677-z	2015	Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.	NOTCH1
26588464	10.1371/journal.pone.0143275	2015	The Chromatin Regulator CHD8 Is a Context-Dependent Mediator of Cell Survival in Murine Hematopoietic Malignancies.	NOTCH1
23697875	10.3109/10428194.2013.807510	2014	The importance of Notch signaling in peripheral T-cell lymphomas.	NOTCH1
23774673	10.1038/leu.2013.183	2014	Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.	NOTCH1
23841506	10.3109/10428194.2013.823493	2014	Novel targeted therapies in acute lymphoblastic leukemia.	NOTCH1
24047107	10.3109/10428194.2013.834054	2014	Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?	NOTCH1
24047479	10.3109/10428194.2013.845882	2014	Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.	NOTCH1
24140475	10.1016/j.cellsig.2013.09.021	2014	New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.	NOTCH1
24249312	10.1002/pbc.24852	2014	Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.	NOTCH1
24301524	10.1038/leu.2013.366	2014	Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia.	NOTCH1
24326827	10.1177/1066896913513833	2014	Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.	NOTCH1
24329526	10.1089/dna.2013.2199	2014	The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.	NOTCH1
24384093	10.1016/j.canlet.2013.12.027	2014	Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.	NOTCH1
24394663	10.1182/blood-2013-08-522698	2014	c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.	NOTCH1
24401270	10.1172/JCI65093	2014	Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.	NOTCH1
24421328	10.1182/blood-2013-11-516229	2014	How we treat Richter syndrome.	NOTCH1
24424791	10.1002/pbc.24803	2014	Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.	NOTCH1
24465765	10.1371/journal.pone.0085883	2014	LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.	NOTCH1
24485662	10.1016/j.celrep.2014.01.007	2014	ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.	NOTCH1
24505083	10.1182/blood-2013-01-477620	2014	Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy.	NOTCH1
24530429	10.1016/j.mrfmmm.2014.01.007	2014	Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.	NOTCH1
24548608	10.1016/j.clml.2013.12.016	2014	Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.	NOTCH1
24584072	10.1038/ng.2913	2014	An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.	NOTCH1
24584351	10.3324/haematol.2013.101725	2014	DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia.	NOTCH1
24586197	10.1371/journal.pgen.1004167	2014	Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.	NOTCH1
24596208	10.1158/2159-8290.CD-RW2014-017	2014	Activation of PP2A by perphenazine induces apoptosis in T-ALL.	NOTCH1
24597984	10.3109/10428194.2014.898760	2014	NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.	NOTCH1
24619868	10.1002/gcc.22163	2014	Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.	NOTCH1
24661878	10.1016/j.bbrc.2014.03.048	2014	Functional expression of P2X family receptors in macrophages is affected by microenvironment in mouse T cell acute lymphoblastic leukemia.	NOTCH1
24687960	10.1084/jem.20122727	2014	Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.	NOTCH1
24690100	10.1111/bjh.12866	2014	NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.	NOTCH1
24710376	10.1038/nm.3528	2014	Cancer therapy resistance: chasing epigenetics.	NOTCH1
24726647	10.1016/j.bbrc.2014.04.003	2014	Activation of Notch1 promotes development of human CD8(+) single positive T cells in humanized mice.	NOTCH1
24727675	10.1038/leu.2014.134	2014	An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.	NOTCH1
24729385	10.1002/gcc.22176	2014	14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.	NOTCH1
24740809	10.1182/blood-2014-01-547695	2014	Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.	NOTCH1
24795015	10.1158/2159-8290.CD-RW2014-060	2014	Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL.	NOTCH1
24819383	10.1016/j.jbior.2014.04.004	2014	Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.	NOTCH1
24828041	10.1038/nature13317	2014	Cell competition is a tumour suppressor mechanism in the thymus.	NOTCH1
24857884	10.1097/MOH.0000000000000057	2014	Do mantle cell lymphomas have an 'Achilles heel'?	NOTCH1
24857886	10.1097/MOH.0000000000000058	2014	The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia.	NOTCH1
24895337	10.3324/haematol.2013.099515	2014	MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.	NOTCH1
24952875	10.1186/1471-2407-14-463	2014	FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.	NOTCH1
24959528	10.3389/fped.2014.00054	2014	The challenge of targeting notch in hematologic malignancies.	NOTCH1
24989265	10.7534/j.issn.1009-2137.2014.03.009	2014	[Expression of P2X family receptors in peritoneal macrophages of mouse with acute T lymphoblastic leukemia].	NOTCH1
25043004	10.1038/nature13495	2014	Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia.	NOTCH1
25083870	10.1016/j.cell.2014.05.049	2014	Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.	NOTCH1
25141821	10.1002/path.4428	2014	Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.	NOTCH1
25156146	10.1007/s10495-014-1029-5	2014	Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.	NOTCH1
25185196	10.1158/2159-8290.CD-RW2014-162	2014	NOTCH1 downregulation contributes to PI3K inhibitor resistance in T-ALL.	NOTCH1
25194570	10.1038/nm.3665	2014	A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.	NOTCH1
25201756	10.1016/j.exphem.2014.08.006	2014	Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.	NOTCH1
25218362	10.1007/s11899-014-0223-4	2014	Risk factors for Richter syndrome in chronic lymphocytic leukemia.	NOTCH1
25238756	10.4049/jimmunol.1300337	2014	Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response.	NOTCH1
25295936	10.1038/nm.3711	2014	Thymocyte transformation enhanced.	NOTCH1
25344525	10.3324/haematol.2014.115683	2014	The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.	NOTCH1
25344755	10.1038/ncb3046	2014	Cyclin C is a haploinsufficient tumour suppressor.	NOTCH1
25358351	10.1038/ncb3055	2014	Cyclin C surprises in tumour suppression.	NOTCH1
25366136	10.1186/s13045-014-0071-7	2014	Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen.	NOTCH1
25367958	10.1158/2159-8290.CD-RW2014-196	2014	T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.	NOTCH1
25369933	10.1073/pnas.1407079111	2014	Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.	NOTCH1
25404153	10.1615/critrevoncog.2014011794	2014	Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?	NOTCH1
25471034	10.2217/fon.14.81	2014	Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development.	NOTCH1
25483078	10.4161/15384101.2014.964118	2014	KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo.	NOTCH1
25522233	10.1371/journal.pgen.1004768	2014	SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.	NOTCH1
25543484	10.7534/j.issn.1009-2137.2014.06.021	2014	[Effect of silencing NOTCH1 gene by shRNA interference on AKT/mTOR pathway in mantle cell lymphoma].	NOTCH1
22349824	10.1038/onc.2012.42	2013	Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration.	NOTCH1
22814294	10.1038/leu.2012.176	2013	Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.	NOTCH1
22846929	10.1038/leu.2012.192	2013	Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.	NOTCH1
22968660	10.1007/s00277-012-1561-8	2013	Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.	NOTCH1
23040356	10.1016/j.bcmd.2012.09.001	2013	BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.	NOTCH1
23108395	10.1038/onc.2012.482	2013	DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.	NOTCH1
23161489	10.1158/0008-5472.CAN-12-1389	2013	Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.	NOTCH1
23289374	10.1186/1756-8722-6-3	2013	Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.	NOTCH1
23295735	10.1038/leu.2012.357	2013	NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.	NOTCH1
23341344	10.1002/gcc.22039	2013	The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.	NOTCH1
23343182	10.3109/10428194.2013.769049	2013	New boys in town: prognostic role of SF3B1, NOTCH1 and other cryptic alterations in chronic lymphocytic leukemia and how it works.	NOTCH1
23349303	10.3324/haematol.2012.073585	2013	NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.	NOTCH1
23354995	10.1007/s00277-012-1664-2	2013	Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia.	NOTCH1
23359050	10.1371/journal.pone.0053190	2013	FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.	NOTCH1
23359069	10.1084/jem.20121527	2013	Notch activation inhibits AML growth and survival: a potential therapeutic approach.	NOTCH1
23373539	10.1111/bjh.12231	2013	KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.	NOTCH1
23396305	10.1182/blood-2012-12-474148	2013	Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.	NOTCH1
23407552	10.1182/blood-2013-01-478834	2013	The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.	NOTCH1
23410974	10.1016/j.ccr.2013.01.011	2013	Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.	NOTCH1
23435313	10.1016/j.exphem.2013.02.006	2013	Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.	NOTCH1
23445313	10.1111/bjd.12071	2013	Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.	NOTCH1
23480493	10.3109/10428194.2013.783913	2013	Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?	NOTCH1
23603912	10.1182/blood-2012-11-465138	2013	Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.	NOTCH1
23667468	10.1371/journal.pone.0062346	2013	Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma.	NOTCH1
23673656	10.1074/jbc.M113.475376	2013	Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.	NOTCH1
23685026	10.1016/j.jaad.2013.04.027	2013	A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.	NOTCH1
23687089	10.1182/blood-2013-03-491092	2013	Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.	NOTCH1
23692084	10.1111/cpr.12037	2013	Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner.	NOTCH1
23695450	10.1097/MOH.0b013e3283623c61	2013	Early T-cell precursor acute lymphoblastic leukaemia.	NOTCH1
23730497	10.1177/2040620712471368	2013	The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.	NOTCH1
23788636	10.1074/jbc.M113.451625	2013	Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.	NOTCH1
23791182	10.1016/j.cell.2013.05.041	2013	The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.	NOTCH1
23825651	10.1371/journal.pone.0067306	2013	Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.	NOTCH1
23827704	10.1016/j.stem.2013.06.008	2013	Notching up MYC gives a LIC.	NOTCH1
23857984	10.1084/jem.20122516	2013	The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.	NOTCH1
23873701	10.1002/gcc.22088	2013	BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.	NOTCH1
23898065		2013	Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells.	NOTCH1
23908464	10.1182/blood-2013-05-500850	2013	Genetic loss of SH2B3 in acute lymphoblastic leukemia.	NOTCH1
23982259	10.1007/s11033-013-2654-8	2013	Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.	NOTCH1
24014297	10.1007/978-1-4614-8051-8_8	2013	Richter syndrome.	NOTCH1
24041576	10.1182/blood-2013-08-460311	2013	Genome sequencing of lymphoid malignancies.	NOTCH1
24046360	10.1242/dmm.012575	2013	A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).	NOTCH1
24090996	10.1016/j.leukres.2013.09.007	2013	Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model.	NOTCH1
24127483	10.1084/jem.20131448	2013	Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.	NOTCH1
24145436	10.1073/pnas.1314608110	2013	Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.	NOTCH1
24166518	10.1200/JCO.2012.48.5292	2013	Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.	NOTCH1
24174626	10.1182/blood-2012-08-451278	2013	In vivo leukemogenic potential of an interleukin 7 receptor α chain mutant in hematopoietic stem and progenitor cells.	NOTCH1
24370020	10.7534/j.issn.1009-2137.2013.06.008	2013	[Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia].	NOTCH1
24386421	10.1371/journal.pone.0084841	2013	Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells.	NOTCH1
21984373	10.1002/path.3015	2012	Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.	NOTCH1
22116551	10.1038/leu.2011.328	2012	Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.	NOTCH1
22171922	10.1111/j.1365-2141.2011.08980.x	2012	Absence of NOTCH1 gene mutations in MALT lymphomas.	NOTCH1
22210878	10.1182/blood-2011-11-391474	2012	Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.	NOTCH1
22311010	10.1007/s11033-011-1424-8	2012	The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.	NOTCH1
22348144	10.1371/journal.pone.0032047	2012	The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion.	NOTCH1
22357466		2012	[Gene expression of Notch1 and Jagged1 in children with acute leukemia].	NOTCH1
22393458	10.1371/journal.pone.0032944	2012	Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice.	NOTCH1
22424712	10.1016/j.leukres.2012.02.013	2012	Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.	NOTCH1
22491738	10.3324/haematol.2011.059030	2012	The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.	NOTCH1
22510873	10.1182/blood-2011-10-388504	2012	An activating intragenic deletion in NOTCH1 in human T-ALL.	NOTCH1
22571487	10.1111/j.1365-2141.2012.09155.x	2012	Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.	NOTCH1
22673746	10.1007/82_2012_232	2012	Recent advances on NOTCH signaling in T-ALL.	NOTCH1
22695916	10.1007/82_2012_231	2012	Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.	NOTCH1
22718117	10.1038/jid.2012.203	2012	NOTCH1 signaling as a therapeutic target in Sézary syndrome.	NOTCH1
22768113	10.1371/journal.pone.0039725	2012	NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.	NOTCH1
23022380	10.1016/j.molcel.2012.08.022	2012	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	NOTCH1
23086478	10.1038/nm.2960	2012	NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species.	NOTCH1
20965628	10.1016/j.blre.2010.09.004	2011	Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.	NOTCH1
21052088	10.1038/leu.2010.255	2011	Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.	NOTCH1
21326611	10.1371/journal.pone.0016761	2011	Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.	NOTCH1
21464222	10.1084/jem.20102384	2011	Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL.	NOTCH1
21556011	10.1038/leu.2011.96	2011	Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia.	NOTCH1
21625236	10.1038/leu.2011.130	2011	Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL.	NOTCH1
21631271	10.5858/2009-0691-OA.1	2011	Uniform expression of Notch1, suppressor of B-cell-specific gene expression, in plasmablastic lymphoma.	NOTCH1
21775206	10.1016/j.it.2011.06.005	2011	Notch in T-ALL: new players in a complex disease.	NOTCH1
21807868	10.1084/jem.20110121	2011	High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.	NOTCH1
21835957	10.1182/blood-2011-02-334219	2011	Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.	NOTCH1
21880637	10.3324/haematol.2011.043083	2011	Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.	NOTCH1
21979940	10.1182/blood-2011-08-376061	2011	Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?	NOTCH1
22006338	10.1073/pnas.1114669108	2011	Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.	NOTCH1
22022427	10.1371/journal.pone.0025645	2011	Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.	NOTCH1
19631984	10.1016/j.leukres.2009.06.026	2010	T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.	NOTCH1
19847202	10.1038/leu.2009.221	2010	Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies.	NOTCH1
20348880	10.1038/modpathol.2010.67	2010	Notch1 in primary effusion lymphoma: a clinicopathological study.	NOTCH1
20538790	10.1182/blood-2009-12-260216	2010	Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.	NOTCH1
20683149	10.3233/DMA-2010-0715	2010	Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL.	NOTCH1
20823234	10.1073/pnas.1010722107	2010	Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.	NOTCH1
20861909	10.1038/leu.2010.204	2010	NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.	NOTCH1
20861920	10.1038/leu.2010.205	2010	NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.	NOTCH1
20944675	10.1038/leu.2010.203	2010	The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.	NOTCH1
21302811	10.3727/096504010x12864748215007	2010	Mutations in the HD and PEST domain of Notch-1 receptor in T-cell acute lymphoblastic leukemia: report of novel mutations from Indian population.	NOTCH1
18984862	10.1182/blood-2008-02-138172	2009	NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.	NOTCH1
19057901	10.1007/s00277-008-0646-x	2009	Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.	NOTCH1
19091404	10.1016/j.leukres.2008.10.026	2009	Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.	NOTCH1
19109228	10.1182/blood-2008-10-184069	2009	NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.	NOTCH1
19151773	10.1038/leu.2008.366	2009	A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia.	NOTCH1
19160126	10.1080/10428190802553257	2009	Down-regulation of Notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy.	NOTCH1
19239437	10.1111/j.1600-0463.2008.00023.x	2009	Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.	NOTCH1
19245433	10.1111/j.1365-2141.2009.07607.x	2009	FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.	NOTCH1
19339697	10.1182/blood-2008-11-190090	2009	Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.	NOTCH1
19340001	10.1038/leu.2009.64	2009	The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	NOTCH1
19635999	10.1200/JCO.2009.22.0996	2009	Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.	NOTCH1
19704010	10.1128/MCB.00406-09	2009	Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.	NOTCH1
19778842	10.3816/CLM.2009.s.013	2009	Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.	NOTCH1
19794083	10.3324/haematol.2008.005272	2009	Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.	NOTCH1
19907488	10.1038/nature08543	2009	Direct inhibition of the NOTCH transcription factor complex.	NOTCH1
20008221	10.1182/asheducation-2009.1.353	2009	The role of NOTCH1 signaling in T-ALL.	NOTCH1
17874453	10.1002/ajh.21044	2008	Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.	NOTCH1
17901244	10.1182/blood-2007-02-074690	2008	NOTCH1 mutation can be an early, prenatal genetic event in T-ALL.	NOTCH1
17980397	10.1016/j.virol.2007.10.009	2008	An auto-regulatory loop for EBV LMP2A involves activation of Notch.	NOTCH1
18411416	10.1182/blood-2007-12-130096	2008	NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.	NOTCH1
18449208	10.1038/leu.2008.101	2008	Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.	NOTCH1
18663146	10.1182/blood-2008-03-147587	2008	K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.	NOTCH1
17252014	10.1038/sj.leu.2404546	2007	NOTCH1-induced T-cell leukemia in transgenic zebrafish.	NOTCH1
17560996	10.1016/j.yexcr.2007.04.027	2007	Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.	NOTCH1
17646408	10.1084/jem.20070872	2007	The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.	NOTCH1
17671232	10.1182/blood-2007-02-073486	2007	Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.	NOTCH1
18056171	10.1158/1078-0432.CCR-07-1474	2007	Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia.	NOTCH1
18184405	10.1111/j.1600-0463.2007.00751.x	2007	Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.	NOTCH1
16449526	10.1182/blood-2005-09-3551	2006	Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.	NOTCH1
16651424	10.1158/0008-5472.CAN-05-3830	2006	Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.	NOTCH1
16688224	10.1038/sj.leu.2404258	2006	CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.	NOTCH1
16707600	10.1158/1078-0432.CCR-05-2832	2006	NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.	NOTCH1
16738328	10.1128/MCB.01655-05	2006	Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.	NOTCH1
16880534	10.1128/MCB.02478-05	2006	Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.	NOTCH1
16887975	10.4049/jimmunol.177.4.2153	2006	Structurally distinct ligand-binding or ligand-independent Notch1 mutants are leukemogenic but affect thymocyte development, apoptosis, and metastasis differently.	NOTCH1
17107915	10.1080/10428190600773339	2006	NOTCH1 mutations are rare in acute myeloid leukemia.	NOTCH1
15756589	10.1007/s00428-005-1214-6	2005	Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma.	NOTCH1
16079893	10.1038/sj.leu.2403896	2005	Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children.	NOTCH1
16298817	10.1532/IJH97.05096	2005	Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.	NOTCH1
15472075	10.1126/science.1102160	2004	Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.	NOTCH1
12509463	10.1128/MCB.23.2.655-664.2003	2003	Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.	NOTCH1
12532332	10.1002/jcb.10383	2003	Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture.	NOTCH1
11964309	10.1182/blood.v99.9.3398	2002	Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.	NOTCH1
11739188	10.1182/blood.v98.13.3793	2001	A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer.	NOTCH1
9111040	10.1074/jbc.272.17.11336	1997	Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.	NOTCH1
1831692	10.1016/0092-8674(91)90111-b	1991	TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.	NOTCH1
